Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
US Army
Harvard Business School
Queensland Health
Mallinckrodt
Deloitte
Cantor Fitzgerald
Chinese Patent Office
Citi

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018343

« Back to Dashboard

NDA 018343 describes CAPOTEN, which is a drug marketed by Par Pharm and is included in one NDA. Additional details are available on the CAPOTEN profile page.

The generic ingredient in CAPOTEN is captopril. There are fourteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the captopril profile page.

Summary for 018343

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 018343

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired Orange Book Patents for NDA: 018343

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-004Jun 13, 1995► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-004Jun 13, 1995► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-005Jan 17, 1985► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-007Jun 13, 1995► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-007Jun 13, 1995► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Par PharmCAPOTENcaptoprilTABLET;ORAL018343-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Covington
Fuji
Merck
Colorcon
Healthtrust
Federal Trade Commission
Queensland Health
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot